<DOC>
	<DOCNO>NCT02089464</DOCNO>
	<brief_summary>A pivotal , prospective , multi-center , randomize , control , double-blinded study combine active Nexstim NBS-guided 1Hz rTMS sham-rTMS target healthy hemisphere standardize task orient rehabilitation conduct patient post-stroke motor impairment . The therapy provide 6 week primary outcome assessed 6 month later .</brief_summary>
	<brief_title>Niche Trial : Navigated Inhibitory rTMS Contralesional Hemisphere Trial</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>Inclusion Criteria : ≥ 18 year age An ischemic hemorrhagic stroke suffer 312 month prior study ; know brain abnormality history ; A onesided stroke result upper extremity paresis A ChedokeMcMaster Stroke Assessment arm stage hand stage 36 affect limb Exclusion Criteria Implanted metallic part implant electronic device , include pacemaker , defibrillator , implant medication pump ; Pregnant try become pregnant ; Lack pregnancy establish female childbearing potential negative urine pregnancy test screening . Active alcohol abuse , illicit drug use drug abuse significant mental illness Patients suffer depression measure score &gt; 10 Patient Health Questionnaire ( PHQ9 ) . For clarity , patient diagnose depression control stable antidepressive medication PHQ9 &lt; 10 eligible participate trial . History epilepsy , define least two unprovoked seizure occur great 24 hour apart diagnosis epilepsy syndrome , OR seizure within last 12 month . Any condition would prevent subject give voluntary informed consent ; An implanted brain stimulator ; Any metal head exception dental work ferromagnetic metal elsewhere body ; Enrolled plan enroll interventional trial study ; Scalp wound infection ; Claustrophobia preclude MRI ; A fixed contraction deformity affect limb would prevent normal dexterity patient neurologically intact ; Excessive spasticity indicate Modified Ashworth Spasticity ( MAS ) Scale &gt; 2/4 either elbow flexor , wrist flexor finger flexor affect limb ; previous stroke residual deficit ( TIAs reason exclusion ) ; premorbid ( retrospective ) modify Rankin Scale ( mRS ) score ≥2 aetiology ; concurrent progressive neurologic disorder , acute coronary syndrome , severe heart disease ( NYHA Classification &gt; 3 ) , major medical condition , confirm suspected lowerlimb fracture prevent mobilization , patient require palliative care patient plan undergo occupational therapy 6 week active treatment period trial ( see section 5.2 study schedule ) provide study A recent injection botulinium toxin affect upper limb last 3 month , need injection botulinum toxin anytime study period follow . A recent injection phenol affect upper limb last 6 month , need injection phenol anytime study period follow . Ataxia measure score &gt; 1 item 7 ( limb ataxia ) NIH stroke scale . Severe sensory deficit measure score 2 item 8 NIH stroke scale . Severe aphasia measure score &gt; 2 item 9 ( best language ) NIH stroke scale . Severe neglect measure score 2 item 11 ( extinction inattention ) NIH stroke scale . Patients unable comprehend follow verbal command Based PI 's local physician 's assessment patient unable tolerate trial procedure due medical condition A Mini mental status exam ( MMSE ) &lt; 25 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>